IDH1 GENE MUTATION
Clinical trials for IDH1 GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new IDH1 GENE MUTATION trials appear
Sign up with your email to follow new studies for IDH1 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted drug trial offers hope for Tough-to-Treat bone cancer
Disease control OngoingThis study is testing whether the drug AG-120 is safe and effective for people with advanced or returning chondrosarcoma, a type of bone cancer, that has a specific genetic change called an IDH1 mutation. The main goal is to see if the drug can stop the cancer from growing. The t…
Matched conditions: IDH1 GENE MUTATION
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New hope for young brain cancer patients in Early-Stage trial
Disease control OngoingThis early-stage study is testing a new two-drug combination (BGB-290 and temozolomide) for adolescents and young adults with specific types of brain tumors that have returned or are newly diagnosed. The main goal is to find the safest dose and understand the side effects. Resear…
Matched conditions: IDH1 GENE MUTATION
Phase: PHASE1 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Mar 11, 2026 14:52 UTC